ReviewFrontiers in pharmacology2019

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Yoshio Goshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.